Evaluation of solute permeation through the stratum corneum: Lateral bilayer diffusion as the primary transport mechanism

Journal of Pharmaceutical Sciences

Volumn 86, Issue 10, 1997, Pages 1162-1172

  Johnson, Mark E ^a   Blankschtein, Daniel ^a   Langer, Robert ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; BILAYER MEMBRANE; DRUG PENETRATION; LIPID BILAYER; MATHEMATICAL MODEL; MEMBRANE PERMEABILITY; PARTITION COEFFICIENT; STRATUM CORNEUM;

EID: 0030886388     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960198e     Document Type: Article

References (95)

1. Johnson, M. E.; Mitragotri, S.; Patel, A.; Blankschtein, D.; Langer, R. J. Pharm. Sci. 1996, 85, 670-679.
2. Mitragotri, S.; Edwards, D.; Blankschtein, D.; Langer, R. J. Pharm. Sci. 1995, 84, 697-706.
3. Peck, K. D.; Ghanem, A.; Higuchi, W. I. Pharm. Res. 1994, 11, 1306-1314.
4. Yoneto, K.; Li, S. K.; Ghanem, A. H.; Crommelin, D. J.; Higuchi, W. I. J. Pharm. Sci. 1995, 84, 853-861.
5. Swartzendruber, D. C.; Wertz, P. W.; Kitko, D. J.; Madison, K. C.; Downing, D. T. J. Invest. Dermatol. 1989, 92, 251-257.
6. Elias, P. M.; Menon, G. K. Adv. Lipid Res. 1991, 24, 1-26.
7. Madison, K. C.; Swartzendruber, D. C.; Wertz, P. W.; Downing, D. T. J. Invest. Dermatol. 1987, 88, 714-718.
8. Odland, G. F.; Holbrook, K. Curr. Probl. Dermatol. 1981, 9, 29-49.
9. Bouwstra, J. A.; Gooris, G. S.; van der Spek, J. A.; Bras, W. J. Invest. Dermatol. 1991, 97, 1005-1012.
10. Garson, J. C.; Doucet, J.; Leveque, J. L.; Tsoucaris, G. J. Invest. Dermatol. 1991, 96, 43-49.
11. Friberg, S. E.; Osborne, D. W. J. Disp. Sci. Tech. 1985, 6, 485-495.
12. Wertz, P. W.; Downing, D. T. In Transdermal Drug Delivery: Development Issues and Research Initiatives; Hadgraft, J.; Guy, R. H.; Eds.; Marcell Dekker: New York, 1989; pp 1-22.
13. Mitragotri, S.; Blankschtein, D.; Langer, R. Pharm. Res. 1996, 13, 411-420.
14. Raykar, P. V., Fung, M. C.; Anderson. B. D. Pharm. Res. 1988, 5, 140-150.
15. Potts, R. O.; Francoeur, M. L. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 3871-3883.
16. Knutson, K.; Krill, S. I.; Lambert, W. J.; Higuchi, W. I. In Controlled Release Technology: Pharmaceutical Applications; Lee, P. I., Good, W. R., Eds.; American Chemical Society: Washington, DC, 1987; pp 241-266.
17. Peck, K. D.; Ghanem, A. H.; Higuchi, W. I. J. Pharm. Sci. 1995, 84, 975-982.
18. DeYoung, L. R.; Dill, K. A. J. Phys. Chem. 1990, 94, 801-809.
19. Arrowsmith, M.; Hadgraft, J.; Kellaway, I. W. Biochim. Biophys. Acta 1983, 750, 149-156.
20. Knepp, V. M.; Guy, R. H. J. Phys. Chem. 1989, 93, 6817-6823.
21. Vaz, W. L. C.; Goodsaid-Salduondo, F.; Jacobson, K. FEBS Lett. 1984, 174, 199-207.
22. Tocanne, J. F.; Dupou-Cezanne, L.; Lopez, A.; Tournier, J. F. FEBS Lett. 1989, 257, 10-16.
23. Almeida, P. F. F.; Vaz, W. L. C.; Thompson, T. E. Biochemistry 1992, 31, 6739-6747.
24. Lieb, W. R.; Stein, W. D. J. Membr. Biol. 1986, 92, 111-119.
25. Cohen, B. E.; Bangham, A. D. Nature 1972, 236, 173-174.
26. Potts, R. O.; Guy, R. H. Pharm. Res. 1992, 9, 663-669.
27. Cooper, E. R.; Kasting, G. J. Controlled Release 1987, 6, 23-35.
28. Vaara, M.; Plachy, W. Z.; Nikaido, H. Biochim. Biophys. Acta 1990, 1024, 152-158.
29. Anderson, B. D.; Higuchi, W. I.; Raykar, P. V. Pharm. Res. 1988, 5, 566-573.
30. Johnson, M. E.; Berk, D.; Blankschtein, D.; Golan, D.; Jain, R.; Langer, R. Biophys. J. 1996, 71, 2656-2668.
31. Zhang, F.; Lee, G. M.; Jacobson, K. BioEssays 1993, 15, 579-588.
32. Axelrod, D.; Koppel, D. E.; Schlessinger, J.; Elson, E.; Webb, W. W. Biophys. J. 1976, 16, 1055-1069.
33. Berk, D. A.; Yuan, F.; Leunig, M.; Jain, R. K. Biophys. J. 1993, 65, 2428-2436.
34. Yguerabide, J., J. A. Schmidt, and E. E. Yguerabide. Biophys. J. 1982, 39, 69-75.
35. Saffman, P. G.; Delbrück, M. Proc. Natl. Acad. Sci. U.S.A. 1975, 72, 3111-3113.
36. Diamond, J. M.; Katz, Y. J. Membr. Biol. 1974, 17, 121-154.
37. Miller, D. M. Biochim. Biophys. Acta 1991, 1065, 75-81.
38. Brunner, J.; Graham, D. E.; Hauser, H.; Semenza, G. J. Membr. Biol. 1980, 57, 133-141.
39. Koefoed, P.; Brahm, J. Biochim. Biophys. Acta 1994, 1195, 55-62.
40. Cullis, P. R.; Hope, M. J.; Bally, M. B.; Madden, R. D.; Mayer, L. D.; Janoff, A. S. In Liposomes: From Biophysics to Therapeutics; Ostro, M. J., Ed.; Marcel Dekker: New York, 1987; pp 39-72.
41. Lampe, M. A.; Williams, M. L.; Elias, P. E. J. Lipid Res. 1983, 24, 131-140.
42. Menton, D. N. Am. J. Anat. 1976, 145, 1-22.
43. Mershon, M. M. In Applied Chemistry at Protein Interfaces; Gould, R. F., Ed.; American Chemical Society: Washington, D.C., 1975; pp 41-73.
44. Wildnauer, R. H.; Miller, D. L.; Humphries, W. T. In Applied Chemistry at Protein Interfaces; Gould, R. F., Ed.; American Chemical Society: Washington, D.C., 1975; pp 74-124.
45. Cussler, E. L.; Hughes, S. E.; Ward, W. J.; Aris, R. J. Membr. Sci. 1988, 38, 161-174.
46. Elias, P. M.; Friend, D. S. J. Cell Biol. 1975, 65, 180-191.
47. Lampe, M. A.; Burlingame, A. L.; Whitney, J.; Williams, M. L.; Brown, B. E.; Roitman, E.; Elias, P. M. J. Lipid Res. 1983, 24, 120-130.
48. Miller, B. A.; Cambell, R.; Bornett, G.; Weiss, A., Jr. Supercritical fluid extraction of lipids from human skin. Proceedings of the International Symposium on Supercritical Chromatography and Fluid Extraction, Park City, Utah, 1991, 117-118.
49. Potts, R. O.; Francoeur, M. L. J. Invest. Dermatol. 1991, 96, 495-99.
50. Michaels, A. S.; Chandraskeran, S. K.; Shaw, J. E. Am. Inst. Chem. Eng. 1975, 21, 985-996.
51. Hatcher, M. E.; Plachy, W. Z. Biochim. Biophys. Acta 1993, 1149, 73-78.
52. Williams, A. C.; Cornwell, P. A.; Barry, B. W. Int. J. Pharm. 1992, 86, 69-77.
53. Leo, A.; Hansch, C.; Elkins, D. Chem. Rev. 1971, 71, 525-554.
54. Hansch, C.; Leo, A. In Substituent Constants for Correlation Analysis in Chemistry and Biology; Wiley: New York, 1979.
55. Scheuplein, R. J.; Blank, I. H. Physiol. Rev. 1971, 51, 702-747.
56. Roberts, M. S.; Anderson, R. A.; Swarbrick, J. J. Pharm. Pharmacol. 1977, 29, 677-683.
57. Scheuplein, R. J.; Blank, I. H.; Brauner, G. J.; MacFarlane, D. J. J. Invest. Dermatol. 1969, 52, 63-70.
58. Johnson, M. E.; Blankschtein, D.; Langer, R. J. Pharm. Sci. 1995, 84, 1144-1146.
59. (b) Johnson, M. E., Ph.D. Thesis, Massachusetts Institute of Technology, 1996.
60. Bunge, A. L.; Creek, R. L. Pharm. Res. 1995, 12, 88-95.
61. Morimoto, Y.; Hatanaka, T.; Sugibayashi, K.; Omiya, H. J. Pharm. Pharmacol. 1992, 44, 634-639.
62. Anderson, B. D.; Raykar, P. V. J. Invest. Dermatol. 1989, 93, 280-86.
63. Flynn, G. L. In Principles of Route-to-Route Extrapolation for Risk Assessment; Gerrity, T. R.; Henry, C. J., Ed.; Elsevier: New York, 1990; pp 93-127.
64. Kasting, G. B.; Smith, R. L.; Cooper, E. R. In Pharmacology and the Skin; Shroot, B.; Schaefer, H.; Valbone, Eds.; Karger and Basel: Switzerland, 1987; pp 138-153.
65. Wilschut, A.; Berge, W. F. T.; Robinson, P. J.; McKone, T. E. Chemosphere 1995, 30, 1275-1296.
66. Kasting, G. B.; Smith, R. L.; Anderson, B. D. In Prodrugs: Topical and Ocular Delivery; Sloan, K. B., Ed.; Marcel Dekker: New York, 1992; pp 117-1161.
67. Cohen, M. H.; Turnbull, D. J. Chem. Phys. 1959, 31, 1164-1169.
68. Lieb, W. R.; Stein, W. D. Nature 1969, 224, 240-243.
69. Homan, R.; Pownall, H. J. Biochim. Biophys. Acta 1988, 938, 155-166.
70. Lipka, G.; Op den Kamp, J. A. F.; Hauser, H. Biochemistry 1991, 30, 11828-11836.
71. Barry, B. W.; Harrison, S. M.; Dugard, P. H. J. Pharm. Pharmacol. 1985, 37, 226-235.
72. Blank, I. H.; McAuliffe, D. J. J. Invest. Dermatol. 1985, 85, 522-526.
73. Scheuplein, R. J. J. Invest. Dermatol. 1967, 48, 79-88.
74. Scheuplein, R. J.; Blank, I. H. J. Invest. Dermatol. 1973, 60, 286-296.
75. Goodman, M.; Barry, B. W. J. Invest. Dermatol. 1988, 91, 323-327.
76. Yum, S.; Lee, E.; Taskovich, L.; Theeuwes, F. In Drug Permeation Enhancement: Theory and Application; Hsieh, D. S., Ed.; Marcel Dekker: New York, 1994; pp 143-170.
77. Galey, W. R.; Lonsdale, H. K.; Nacht, S. J. Invest. Dermatol. 1976, 67, 713-717.
78. Perry, G. E. Percutaneous absorption of drugs across human skin. Ph.D. Thesis, University of Utah, 1990.
79. Knutson, K.; Harrison, D. J.; Pershing, L. K.; Goates, C. Y. J. Controlled Release 1993, 24, 95-108.
80. Dutkiewicz, T.; Tyras, H. Br. J. Ind. Med. 1967, 24, 330-3312.
81. Bond, J. R.; Barry, B. W. J. Invest. Dermatol. 1988, 90, 486-489.
82. Hou, S. Y. E.; Flynn, G. L. J. Invest. Dermatol. 1989, 93, 774-779.
83. Hadgraft, J.; Ridout, G. Int. J. Pharm. 1987, 39, 149-156.
84. Singh, P.; Roberts, M. S. J. Pharm. Exp. Ther. 1994, 268, 144-151.
85. Dutkiewicz, T.; Tyras, H. Br. J. Ind. Med. 1969, 25, 243.
86. Astley, J. P.; Levine, M. J. Pharm. Sci. 1976, 65, 210-215.
87. Bronaugh, R. L.; Stewart, R. F.; Simon, M. J. Pharm. Sci. 1986, 75, 1094-1097.
88. Barber, E. D.; Teetsel, N. M.; Kolberg, K. F.; Guest, D. Fund. Appl. Tox. 1992, 19, 493-497.
89. Harrison, S. M.; Barry, B. W.; Dugard, P. H. J. Pharm. Sci. 1984, 36, 262-262.
90. Barry, B. W.; Harrison, S. M.; Dugard, P. H. J. Pharm. Pharmacol. 1985, 37, 84-90.
91. Bronaugh, R. L.; Congdon, E. R. J. Invest. Dermatol. 1984, 83, 124-127.
92. Roy, S. D.; Flynn, G. L. Pharm. Res. 1989, 6, 825-832.
93. Strichartz, G. R.; Sanchez, V.; Arthur, G. R.; Charetz, R.; Martin, D. Anesth. Analg. 1990, 71, 158-170.
94. Roy, S. D.; Flynn, G. L. Pharm. Res. 1990, 7, 842-847.
95. Katzung, B. G. In Basic and Clinical Pharmacology; Appleton & Lange: Norwalk, CN, 1995.